APO PHARM ApS: Financial statements 2017
CVR: 15226072
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,020,781 and a net result of DKK 51,756 compared with DKK 53,993 the year before. That is an increase of 8.7% compared with the year before. Equity in the 2017 report amounted to DKK 278,882. The solvency ratio was 30%.
- Gross Profit
- DKK 1,020,781
- Profit/Loss
- DKK 51,756
- Equity
- DKK 278,882
- Total Assets
- DKK 930,826
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1 mio. | 52 t. | 279 t. | - |
| 2016 | - | 939 t. | 54 t. | 227 t. | - |
| 2015 | - | 945 t. | 2 t. | 173 t. | - |
| 2014 | - | 1 mio. | -20 t. | 171 t. | - |
| 2013 | - | 783 t. | -126 t. | 191 t. | - |
Official annual report
Keep an eye on APO PHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.